V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008894 | 190006098 | 0 | 19.9 | Curative (C) | 2020-11-23 | 2020-11-27 | EW EuroEwing 2012 Arm B IE | 02 | N | PACLITAXEL | 100552932 |
| 190008914 | 190006099 | 1.82 | 66 | Palliative (P) | 2021-02-05 | 2021-02-16 | NIVOLUMAB | 02 | Y | CISPLATIN + VINORELBINE + RT | 100464288 |
| 190008923 | 190006100 | 1.84 | 77.4 | Adjuvant (A) | 2020-03-19 | 2020-04-14 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | Y | CARBOPLATIN + ETOPOSIDE | 101035732 |
| 190008930 | 190006101 | 0 | 65.6 | null | null | 2018-06-24 | Paclitaxel 7 day | N | N | CAPECITABINE | 101427877 |
| 190008945 | 190006102 | 1.66 | 69 | Neo-adjuvant (N) | 2019-03-04 | 2019-10-14 | Trial Unspecified | 02 | Y | FLUOROURACIL + IRINOTECAN | 100559012 |
| 190008952 | 190006103 | 0 | 74 | Adjuvant (A) | 2021-03-06 | 2021-03-11 | EOX | 02 | N | EPIRUBICIN | 101825577 |
| 190008969 | 190006104 | 1.57 | 92.4 | null | 2021-06-19 | 2021-06-21 | EW EuroEwing 2012 Arm B VDC | 01 | N | NIVOLUMAB | 101317787 |
| 190008971 | 190006105 | 1.63 | 73.4 | Adjuvant (A) | 2019-08-25 | 2020-02-24 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100299477 |
| 190008975 | 190006106 | 1.72 | 33.5 | Palliative (P) | 2018-10-16 | 2018-10-30 | Topotecan (oral) | null | null | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101319053 |
| 190008986 | 190006107 | 0 | 72.1 | Curative (C) | 2019-07-04 | 2019-12-28 | AZACITIDINE + VENETOCLAX | 02 | N | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 101100381 |
| 190008992 | 190006108 | 1.89 | 24.9 | null | 2018-12-09 | 2019-06-06 | MAP | 02 | N | NIVOLUMAB | 100088471 |
| 190008994 | 190006109 | 1.9 | 21 | null | 2021-06-13 | 2021-11-14 | Carboplatin + Paclitaxel (weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101583290 |
| 190009001 | 190006110 | 0 | 77 | null | 2019-10-30 | 2019-11-04 | Trial Unspecified | 02 | N | NIVOLUMAB | 100546701 |
| 190009011 | 190006111 | 1.63 | 88.7 | Palliative (P) | 2019-07-29 | 2019-08-13 | Etoposide oral | 02 | null | NIVOLUMAB | 100810051 |
| 190009022 | 190006112 | 1.43 | 43 | Curative (C) | 2021-10-11 | 2022-01-02 | OST Euramos 1 Closed Trial - IE | 02 | N | ABEMACICLIB + FULVESTRANT | 100629178 |
| 190009034 | 190006113 | 1.86 | 77.9 | Curative (C) | 2016-02-02 | 2016-05-31 | CARBOPLATIN + ETOPOSIDE | 01 | N | GEMCITABINE | 100049352 |
| 190009035 | 190006114 | 0 | 26.1 | Curative (C) | 2016-04-14 | 2016-04-16 | Irinotecan + Temozolomide | 02 | N | CISPLATIN + RT | 100827071 |
| 190009044 | 190006115 | 1.51 | 114.9 | 03 | 2016-09-11 | 2017-03-04 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101825501 |
| 190009051 | 190006116 | null | 80.6 | null | null | 2020-04-14 | Cisplatin | 01 | null | CISPLATIN | 100985989 |
| 190009057 | 190006117 | 0 | 41.3 | 03 | 2018-08-31 | 2018-11-26 | STS Rhabdo RMS 2005 2nd Topo Cyclo | null | null | CAPECITABINE + IRINOTECAN | 100942308 |
| 190009058 | 190006118 | 1.56 | 65 | Adjuvant (A) | 2018-12-26 | 2019-07-04 | Oxaliplatin + Modified de Gramont | 02 | null | PACLITAXEL | 100979612 |
| 190009074 | 190006119 | 1.66 | 75.6 | Curative (C) | 2018-02-10 | 2018-02-15 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100895919 |
| 190009075 | 190006120 | 1.85 | 61.3 | Palliative (P) | 2016-12-12 | 2016-12-19 | Trial Unspecified | 02 | N | FLUOROURACIL + IRINOTECAN | 100596210 |
| 190009108 | 190006121 | 1.82 | 78.7 | Curative (C) | null | 2020-01-03 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | N | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE | 101069425 |
| 190009117 | 190006122 | 1.57 | 18.8 | Neo-adjuvant (N) | 2019-02-22 | 2019-02-27 | CISPLATIN + GEMCITABINE | 02 | N | CAPECITABINE + CARBOPLATIN | 101452979 |
| 190009119 | 190006123 | 1.8 | 94 | Palliative (P) | 2020-09-09 | 2020-09-18 | Folfirinox | 02 | N | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 100889289 |
| 190009136 | 190006124 | 0 | 58.5 | Curative (C) | 2018-05-28 | 2018-05-29 | PEMBROLIZUMAB | 02 | null | TRASTUZUMAB | 100257224 |
| 190009138 | 190006125 | 0 | 23 | Palliative (P) | 2019-07-19 | 2020-01-19 | Oxaliplatin + Modified de Gramont | 02 | N | CISPLATIN + GEMCITABINE | 100191597 |
| 190009142 | 190006126 | 1.76 | 81.6 | Curative (C) | 2018-07-10 | 2018-07-10 | OST Mifamurtide | 02 | N | FULVESTRANT + PALBOCICLIB | 101237553 |
| 190009152 | 190006127 | 1.67 | 72.2 | Palliative (P) | 2018-12-29 | 2019-06-06 | EURAMOS TRIAL | 02 | N | CAPECITABINE + OXALIPLATIN | 100349515 |
| 190009155 | 190006128 | 0 | 57.4 | Neo-adjuvant (N) | 2016-10-21 | 2017-12-18 | CAV | 02 | N | TRIAL | 100425885 |
| 190009160 | 190006129 | 1.53 | 67.3 | null | 2019-01-29 | 2019-01-30 | Cisplatin + Doxorubicin | 01 | N | PEMBROLIZUMAB | 101084493 |
| 190009164 | 190006130 | 1.75 | 82 | Neo-adjuvant (N) | 2020-11-19 | 2021-02-18 | OST Euramos 1 Closed Trial - M | 02 | null | NIVOLUMAB | 100979202 |
| 190009192 | 190006131 | 1.54 | 130.7 | Curative (C) | 2020-06-30 | 2020-12-13 | OST Rel Ifosfamide Etoposide Mtx | 02 | N | ABIRATERONE | 100316469 |
| 190009193 | 190006132 | 1.93 | 71.7 | Curative (C) | 2020-05-11 | 2020-05-31 | Cisplatin | 02 | null | CISPLATIN | 101185191 |
| 190009196 | 190006133 | 1.63 | 86.6 | Palliative (P) | 2021-09-06 | 2022-03-10 | Capecitabine | 02 | Y | CARBOPLATIN + DOCETAXEL | 100289747 |
| 190009199 | 190006134 | 1.67 | 70 | Curative (C) | 2021-06-25 | 2021-06-26 | Capecitabine + Oxaliplatin 21day | 02 | N | CISPLATIN + RT | 100495310 |
| 190009200 | 190006135 | 1.58 | 88 | Adjuvant (A) | null | 2019-05-25 | Avelumab | null | null | CARBOPLATIN + ETOPOSIDE | 100160406 |
| 190009210 | 190006136 | 1.81 | 59.8 | Palliative (P) | 2019-09-17 | 2019-09-21 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100052124 |
| 190009215 | 190006137 | 1.81 | 31 | null | 2018-12-31 | 2018-12-31 | Cisplatin + Radiotherapy | null | Y | CISPLATIN | 100645235 |
| 190009225 | 190006138 | 1.74 | 77.2 | Palliative (P) | 2019-01-27 | 2019-02-11 | Cisplatin + Radiotherapy | 02 | null | CISPLATIN | 101047087 |
| 190009227 | 190006139 | 1.2 | 36.9 | null | null | 2018-08-17 | EW EuroEwing 2012 Arm A VAC | null | null | BLEOMYCIN | 101626008 |
| 190009232 | 190006140 | 1.61 | 57 | Curative (C) | 2021-01-18 | 2021-02-06 | Carboplatin AUC 6 - 10 | 2 | N | CARBOPLATIN | 100547903 |
| 190009237 | 190006141 | 0 | 56.1 | Curative (C) | 2017-02-16 | 2017-02-22 | GemCarbo Days 1+8 | 02 | null | CETUXIMAB | 101461415 |
| 190009242 | 190006142 | 1.57 | 89.7 | Neo-adjuvant (N) | 2019-04-19 | 2019-04-23 | Liposomal Doxorubicin (Caelyx) | 02 | Y | FLUOROURACIL | 100579455 |
| 190009251 | 190006143 | 1.6 | 102.2 | Palliative (P) | null | 2020-09-15 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | null | DOCETAXEL | 100686808 |
| 190009261 | 190006144 | 1.77 | 77.2 | Palliative (P) | 2018-04-20 | 2018-12-05 | Cetuximab + Radiotherapy Maint | 02 | N | FLUOROURACIL + IRINOTECAN | 101383045 |
| 190009262 | 190006145 | 1.5 | 96.7 | Curative (C) | 2020-01-21 | 2020-01-22 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100285155 |
| 190009272 | 190006146 | 1.64 | 75.6 | Palliative (P) | 2020-02-20 | 2020-05-30 | ETOPOSIDE | 02 | N | ICON TRIAL | 100642078 |
| 190009291 | 190006147 | 1.64 | 84.4 | Palliative (P) | 2020-02-29 | 2020-07-26 | NB BEACON Temoz Irin Bev | 02 | null | BEVACIZUMAB | 100709712 |